2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.092

Change

0.00 (0.00)%

Market Cap

USD 0.52B

Volume

0.63M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.73% 41% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.73% 39% F 44% F
Trailing 12 Months  
Capital Gain 21.67% 70% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.67% 69% C- 69% C-
Trailing 5 Years  
Capital Gain 33.64% 60% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.64% 56% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 5.22% 48% F 49% F
Dividend Return 5.22% 47% F 47% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.32% 46% F 56% F
Risk Adjusted Return 39.16% 40% F 45% F
Market Capitalization 0.52B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.